Vikelis, M.; Dermitzakis, E.V.; Xiromerisiou, G.; Rallis, D.; Soldatos, P.; Litsardopoulos, P.; Rikos, D.; Argyriou, A.A.
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. J. Clin. Med. 2023, 12, 4526.
https://doi.org/10.3390/jcm12134526
AMA Style
Vikelis M, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Rikos D, Argyriou AA.
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. Journal of Clinical Medicine. 2023; 12(13):4526.
https://doi.org/10.3390/jcm12134526
Chicago/Turabian Style
Vikelis, Michail, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Dimitrios Rikos, and Andreas A. Argyriou.
2023. "Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry" Journal of Clinical Medicine 12, no. 13: 4526.
https://doi.org/10.3390/jcm12134526
APA Style
Vikelis, M., Dermitzakis, E. V., Xiromerisiou, G., Rallis, D., Soldatos, P., Litsardopoulos, P., Rikos, D., & Argyriou, A. A.
(2023). Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. Journal of Clinical Medicine, 12(13), 4526.
https://doi.org/10.3390/jcm12134526
